Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment
Author:
Affiliation:
1. Department of Hematology, Skåne University Hospital, and Stem Cell Center, Lund University, Lund, Sweden
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/117/12/3473/1492158/zh801211003473.pdf
Reference4 articles.
1. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia.;Kantarjian;Blood,2010
2. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.;Juliusson;Blood,2009
3. Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study.;Juliusson;Br J Haematol,2003
4. Results of risk-adapted therapy in acute myeloid leukaemia: a long-term population-based follow-up.;Wahlin;Eur J Haematol,2009
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How to adjust therapy for elderly AML patients in developing countries?;The Egyptian Journal of Haematology;2023-10
2. Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study;Annals of Hematology;2023-01-25
3. Treatment Pattern, Financial Burden, and Outcomes in Elderly Patients with Acute Myeloid Leukemia in Korea: A Nationwide Cohort Study;International Journal of Environmental Research and Public Health;2022-02-17
4. Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?;Haematologica;2021-07-29
5. Acute myeloid leukaemia in patients we judge as being older and/or unfit;Journal of Internal Medicine;2021-05-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3